Correction: Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice.
[This corrects the article DOI: 10.1371/journal.pone.0218494.].
Main Authors: | Florence Njau, Nelli Shushakova, Heiko Schenk, Vera Christine Wulfmeyer, Robin Bollin, Jan Menne, Hermann Haller |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0244353 |
Similar Items
-
Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice.
by: Florence Njau, et al.
Published: (2020-01-01) -
Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate—Free Radical Scavenger and Growth Factor Inhibition
by: Hermann Haller, et al.
Published: (2017-01-01) -
Calcium dobesilate – a perfect stranger
by: V. Yu. Bogachev, et al.
Published: (2020-06-01) -
Calcium Dobesilate Restores Autophagy by Inhibiting the VEGF/PI3K/AKT/mTOR Signaling Pathway
by: Yue Wang, et al.
Published: (2019-08-01) -
Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
by: Arvindhan Nagarajan, et al.
Published: (2018-08-01)